Simethicone



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 25.0%
Flatulence 16.7%
Abdominal Pain 8.3%
Blood Cholesterol Abnormal 8.3%
Contraception 8.3%
Diarrhoea 8.3%
Hypersensitivity 8.3%
Hypertension 8.3%
Tremor 8.3%
Abnormal Behaviour 14.3%
Death 14.3%
Insomnia 14.3%
Retinopathy 14.3%
Toxicity To Various Agents 14.3%
Unintended Pregnancy 14.3%
Weight Decreased 14.3%
Secondary
Flatulence 26.1%
Gastrooesophageal Reflux Disease 13.0%
Spinal Fracture 8.7%
Blood Cholesterol Abnormal 4.3%
Chest Pain 4.3%
Contraception 4.3%
Diarrhoea 4.3%
Drug Use For Unknown Indication 4.3%
Dyspnoea 4.3%
Genital Herpes 4.3%
Hypersensitivity 4.3%
Hypertension 4.3%
Nausea 4.3%
Osteoporosis 4.3%
Vomiting 4.3%
Death 20.0%
Restless Legs Syndrome 13.3%
Chest Pain 6.7%
Drug Prescribing Error 6.7%
Flatulence 6.7%
Intestinal Obstruction 6.7%
Unintended Pregnancy 6.7%
Vertigo 6.7%
Visual Disturbance 6.7%
Vomiting 6.7%
Weight Decreased 6.7%
Wrong Drug Administered 6.7%
Concomitant
Product Used For Unknown Indication 44.6%
Drug Use For Unknown Indication 25.9%
Pain 4.7%
Hypertension 3.0%
Constipation 2.9%
Nausea 2.5%
Gastrooesophageal Reflux Disease 1.8%
Flatulence 1.7%
Prophylaxis 1.7%
Chronic Obstructive Pulmonary Disease 1.2%
Medical Diet 1.2%
Multiple Myeloma 1.2%
Anxiety 1.0%
Crohn's Disease 1.0%
Chemotherapy 1.0%
Depression 1.0%
Diabetes Mellitus 1.0%
Insomnia 0.9%
Nuclear Magnetic Resonance Imaging 0.9%
Hepatic Neoplasm Malignant 0.8%
Vomiting 13.7%
Death 8.1%
Weight Increased 7.7%
White Blood Cell Count Decreased 7.0%
Weight Decreased 6.7%
Renal Failure Acute 6.3%
Pyrexia 6.0%
Nausea 4.6%
Syncope 4.6%
Urinary Tract Infection 4.6%
Sepsis 3.9%
Tremor 3.9%
Small Intestinal Obstruction 3.2%
Thrombosis 3.2%
Wrist Fracture 3.2%
Duodenal Ulcer 2.8%
Electrocardiogram Qt Prolonged 2.8%
Rectal Haemorrhage 2.8%
Therapeutic Agent Toxicity 2.8%
Pneumonia 2.5%
Interacting
Anxiety 16.7%
Gastrooesophageal Reflux Disease 16.7%
Renal Cancer Metastatic 16.7%
Diabetes Mellitus 8.3%
Hypertension 8.3%
Lung Carcinoma Cell Type Unspecified Stage Iv 8.3%
Nausea 8.3%
Product Used For Unknown Indication 8.3%
Rash 8.3%
Oesophageal Pain 66.7%
Tooth Deposit 33.3%